The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Dapsone and sulfones in dermatology: Overview and update
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Goodman and Gilman's the Pharmacological Basis of Therapeutics
Stigelman, W. H., & Pharm, D. (1986) · Military Medicine · doi:10.1093/milmed/151.1.386 · Cited by 6,782
Tissue Destruction by Neutrophils
Epstein, F. H., & Weiss, S. J. (1989) · New England Journal of Medicine · doi:10.1056/nejm198902093200606 · Cited by 3,950
Tissue Destruction by Neutrophils
(1989) · New England Journal of Medicine · doi:10.1056/nejm198908033210513 · Cited by 3,631
Goodman and Gilman's The Pharmacological Basis of Therapeutics
Hastings, R. C. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540120077042 · Cited by 2,371
Sweet's syndrome (acute febrile neutrophilic dermatosis)
Driesch, P. V. D. (1994) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(94)70215-2 · Cited by 655
Relapsing polychondritis — REPORT OF TEN CASES
Damiani, J. M., & Levine, H. L. (1979) · The Laryngoscope · doi:10.1288/00005537-197906000-00009 · Cited by 614
[Sweet's syndrome. Acute febrile neutrophilic dermatosis].
Bt, G., & Holm, J. O. (1987) · PubMed · Cited by 504
Noninvasive tests of CYP3A enzymes
Watkins, P. B. (1994) · Pharmacogenetics · doi:10.1097/00008571-199408000-00001 · Cited by 408
Clinical Pharmacokinetics of Dapsone
Zuidema, J., Modderman, E. S. M., & Merkus, F. W. H. M. (1986) · Clinical Pharmacokinetics · doi:10.2165/00003088-198611040-00003 · Cited by 252
Rieder, M. J., Uetrecht, J., Shear, N. H., Cannon, M., Miller, M., & Spielberg, S. P. (1989) · Annals of Internal Medicine · doi:10.7326/0003-4819-110-4-286 · Cited by 236
Comparative Safety of Tetracycline, Minocycline, and Doxycycline
Shapiro, L. E. (1997) · Archives of Dermatology · doi:10.1001/archderm.133.10.1224 · Cited by 231
Dapsone: modes of action, toxicity and possible strategies for increasing patient tolerance
COLEMAN, M. D. (1993) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1993.tb00476.x · Cited by 214
Macrolide Antibacterials: Drug Interactions of Clinical Significance
von Rosenstiel, N.-A., & Adam, D. (1995) · Drug Safety · doi:10.2165/00002018-199513020-00005 · Cited by 212
ACQUIRED IMMUNE DEFICIENCY SYNDROME IN BLACK AFRICANS
Clumeck, N., Mascart-Lemone, F., De Maubeuge, J., Brenez, D., & Marcelis, L. (1983) · The Lancet · doi:10.1016/s0140-6736(83)91808-1 · Cited by 209
Pemphigus: a 20-year review of 107 patients treated with corticosteroids
Rosenberg, F. R. (1976) · Archives of Dermatology · doi:10.1001/archderm.112.7.962 · Cited by 196
Mechanism of inhibition of myeloperoxidase by anti-inflammatory drugs
Kettle, A. J., & Winterbourn, C. C. (1991) · Biochemical Pharmacology · doi:10.1016/0006-2952(91)90565-m · Cited by 185
The Inhibition of Polymorphonuclear Leukocyte Cytotoxicity by Dapsone
Stendahl, O., Molin, L., & Dahlgren, C. (1978) · Journal of Clinical Investigation · doi:10.1172/jci109109 · Cited by 177
Dapsone Suppresses Integrin-Mediated Neutrophil Adherence Function
Booth, S. A., Moody, C. E., Dahl, M. V., Herron, M. J., & Nelson, R. D. (1992) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12555654 · Cited by 172
Serious adverse reactions induced by minocycline. Report of 13 patients and review of the literature
Knowles, S. R. (1996) · Archives of Dermatology · doi:10.1001/archderm.132.8.934 · Cited by 172
Antiepileptic Drug Hypersensitivity Syndrome
Schlienger, R. G., & Shear, N. H. (1998) · Epilepsia · doi:10.1111/j.1528-1157.1998.tb01678.x · Cited by 171
25 years' experience of a gluten-free diet in the treatment of dermatitis herpetiformis
Garioch, J., Lewis, H., Sargent, S., LEONARD, J. N., & Fry, L. (2006) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1994.tb08557.x · Cited by 147
Lee, B. L., Ileana, M., Benowitz, N. L., et al. (1989) · Annals of Internal Medicine · doi:10.7326/0003-4819-110-8-606 · Cited by 140
Dapsone hypersensitivity syndrome
Prussick, R. B., & Shear, N. H. (1996) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(96)90667-2 · Cited by 129
Gill, H., Tingle, M. D., & Park, B. K. (1995) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1995.tb05797.x · Cited by 121
Souza, J. P., Boeckh, M., Gooley, T. A., Flowers, M. E. D., & Crawford, S. W. (1999) · Clinical Infectious Diseases · doi:10.1086/313509 · Cited by 118
Vasconcelles, M. J., Bernardo, M. P., King, C., Weller, E. A., & Antin, J. H. (2000) · Transplantation and Cellular Therapy · doi:10.1016/s1083-8791(00)70050-4 · Cited by 116
Inhibition of the human leukocyte enzymes myeloperoxidase and eosinophil peroxidase by dapsone
Bozeman, P. M., Learn, D. B., & Thomas, E. L. (1992) · Biochemical Pharmacology · doi:10.1016/0006-2952(92)90449-s · Cited by 105
Metabolism of dapsone to its hydroxylamine by CYP2E1 in vitro and in vivo*
Mitra, A., Thummel, K. E., Kalhorn, T. F., Kharasch, E. D., Unadkat, J. D., & Slattcry, J. T. (1995) · Clinical Pharmacology & Therapeutics · doi:10.1016/0009-9236(95)90176-0 · Cited by 104
Dapsone toxicity: Some current perspectives
Coleman, M. D. (1995) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(95)00029-1 · Cited by 92
May, D. G., Porter, J., Wilkinson, G. R., et al. (1994) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1994.62 · Cited by 89
Effects of clarithromycin on cytochrome P-450. Comparison with other macrolides.
Tinel, M., Descatoire, V., Larrey, D. G., Loeper, J., Labbe, G., Lettéron, P., & Pessayre, D. (1989) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22274-1 · Cited by 82
Prussick, R. B. (1992) · Archives of Dermatology · doi:10.1001/archderm.1992.01680120082007 · Cited by 77
Mechanisms by which clofazimine and dapsone inhibit the myeloperoxidase system
van Zyl, J. M., Basson, K., Kriegler, A., & van der Walt, B. J. (1991) · Biochemical Pharmacology · doi:10.1016/0006-2952(91)90323-w · Cited by 74
Pharmacokinetic Interactions with Rifampicin
Zilly, W., Breimer, D. D., & Richter, E. A. (1977) · Clinical Pharmacokinetics · doi:10.2165/00003088-197702010-00005 · Cited by 71
Excretion of chloroquine, dapsone and pyrimethamine in human milk.
Edstein, M., Veenendaal, J. R., Newman, K. T., & Hyslop, R. (1986) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1986.tb02967.x · Cited by 70
de Torres, R. A., Barr, M. R., Thorn, M., Gregory, G., Kiely, S., Chanin, E., Carlo, C., Martin, M., & Thornton, J. (1993) · The American Journal of Medicine · doi:10.1016/0002-9343(93)90352-p · Cited by 68
Harvath, L., Yancey, K. B., & Katz, S. I. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.137.4.1305 · Cited by 67
Oral activated charcoal and dapsone elimination
Pj, N., Elonen, E., & Mattila, M. J. (1980) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1980.117 · Cited by 67
Recalcitrant Pyoderma Gangrenosum Treated With Thalidomide
Federman, G. L., & Federman, D. G. (2000) · Mayo Clinic Proceedings · doi:10.4065/75.8.842 · Cited by 65
Martin, M. A. (1992) · Archives of Internal Medicine · doi:10.1001/archinte.1992.00400150053009 · Cited by 58
Dapsone is safe during pregnancy
Kahn, G. (1985) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(85)80416-3 · Cited by 55
Caraco, Y., Wilkinson, G. R., & Wood, A. J. J. (1996) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(96)90196-4 · Cited by 54
Pyoderma gangrenosum--a literature review.
Callen, J., & Wb, T. (1978) · PubMed · Cited by 54
Azoles, a48 llylamines and drug metabolism
Back, D. J., Tjia, J., & ABEL, S. M. (1992) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1992.tb00003.x · Cited by 53
Neonatal Hyperbilirubinemia After Treatment of Maternal Leprosy
Thornton, Y. S., & Bowe, E. T. (1989) · Southern Medical Journal · doi:10.1097/00007611-198905000-00037 · Cited by 49
Dapsone in the Treatment of Pemphigus Vulgaris
Haim, S., & Birnbaum, F. (2009) · Dermatologica · doi:10.1159/000250907 · Cited by 48
Roger, H., Thevenet, J. P., Souteyrand, P., & Sauvezie, B. (1990) · Annals of the Rheumatic Diseases · doi:10.1136/ard.49.3.190 · Cited by 43
A review of inpatients with adverse drug reactions to allopurinol.
Khoo, B. P., & Leow, Y. H. (2000) · PubMed · Cited by 41
Gates, C., & Rees, R. S. (1990) · Toxicon · doi:10.1016/0041-0101(90)90095-o · Cited by 40
Clinical singgnificance of interactions with antifungal agents
BRECKENDRIDGE, A. (1992) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1992.tb00004.x · Cited by 37
Treatment and prophylaxis of Pneumocystis carinii pneumonia.
Castro, M. (1998) · PubMed · Cited by 37
Cutaneous vasculitis in psoriasis.
Wong, S. S., & Marks, R. (1994) · Acta Dermato Venereologica · doi:10.2340/00015555746162 · Cited by 37
Cameron, R., Feuer, G. M., & de la Iglesia, F. A. (1996) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-61013-4 · Cited by 36
Bradshaw, T. P., McMillan, D. C., Crouch, R. K., & Jollow, D. J. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(96)00542-4 · Cited by 35
Vage, C., & Svensson, C. K. (1994) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)07516-6 · Cited by 34
Monitoring for adverse effects from systemic drugs used in dermatology
Wolverton, S. E. (1992) · Journal of the American Academy of Dermatology · doi:10.1016/0190-9622(92)70092-t · Cited by 33
Vitamin E and Dapsone-Induced Hemolysis
Kelly, J. W. (1984) · Archives of Dermatology · doi:10.1001/archderm.1984.01650480044015 · Cited by 30
Pregnancy in Patients With Hansen Disease
Lyde, C. B. (1997) · Archives of Dermatology · doi:10.1001/archderm.1997.03890410079010 · Cited by 27
Eosinophilic Cellulitis in a Child Successfully Treated with Cetirizine
Aroni, M. A. K. (1999) · Acta Dermato Venereologica · doi:10.1080/000155599750010841 · Cited by 26
Manic depression induced by dapsone in patient with dermatitis herpetiformis.
Gawkrodger, D. J. (1989) · BMJ · doi:10.1136/bmj.299.6703.860-c · Cited by 20
Payen, M. C., Wit, S. D., Sommereijns, B., & Clumeck, N. (1997) · Biomedicine & Pharmacotherapy · doi:10.1016/s0753-3322(97)82322-0 · Cited by 19
Polymorphic Acetylation of the Antibacterials, Sulfamethazine and Dapsone, in South Indian Subjects
Peters, J. H., Gordon, G. R., & Karat, A. B. A. (1975) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1975.24.641 · Cited by 17
Treatment and Prophylaxis of Pneumocystis carinii Pneumonia in AIDS Patients
Smith, D. E., & Gazzard, B. (1991) · Drugs · doi:10.2165/00003495-199142040-00006 · Cited by 15
Dietary treatment of dermatitis herpetiformis.
Andersson, H., & Mobacken, H. (1992) · PubMed · Cited by 11
Kinirons, M. T., Krivoruk, Y., Wilkinson, G. R., & Wood, A. J. (1999) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1999.00859.x · Cited by 11
Cited by
Carbon nanotubes for delivery of small molecule drugs
Wong, B. S., Yoong, S. L., Jagusiak, A., Panczyk, T., Ho, H. K., Ang, W. H., & Pastorin, G. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.08.005 · Cited by 585
Dapsone in dermatology and beyond
Wozel, G., & Blasum, C. (2014) · Archives of Dermatological Research · doi:10.1007/s00403-013-1409-7 · Cited by 346
HLA-B*13:01 and the Dapsone Hypersensitivity Syndrome
Zhang, F.-R., Liu, H., Irwanto, A., Fu, X.-A., Li, Y., Yu, G.-Q., Yu, Y.-X., Chen, M.-F., Low, H.-Q., Li, J.-H., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1213096 · Cited by 310
Drug Bioactivation Covalent Binding to Target Proteins and Toxicity Relevance
Zhou, S., Chan, E., Duan, W., Huang, M., & Chen, Y.-Z. (2005) · Drug Metabolism Reviews · doi:10.1081/dmr-200028812 · Cited by 274
Interaction of topical sulfacetamide and topical dapsone with benzoyl peroxide
Dubina, M. I., & Fleischer, A. B. (2009) · Archives of Dermatology · doi:10.1001/archdermatol.2009.186 · Cited by 16
Metadata
- Authors
- Zhu, Y. I., & Stiller, M. J.
- Venue
- Journal of the American Academy of Dermatology
- Publisher
- Elsevier BV
- Published
- 2001-09
- Volume
- 45
- Issue
- 3
- Pages
- 420-434
- ISSN
- 0190-9622 (ISSN-L)
- OpenAlex
- W1993404332
- Cited by
- 441
- References
- 65
- FWCI
- 4.29
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.